Literature DB >> 29659780

Health Outcomes for Clients of Needle and Syringe Programs in Prisons.

Jeffrey V Lazarus1,2, Kelly Safreed-Harmon1,2, Kristina L Hetherington1, Daniel J Bromberg2, Denise Ocampo2, Niels Graf3, Anna Dichtl3, Heino Stöver3, Hans Wolff4.   

Abstract

High levels of drug dependence have been observed in the prison population globally, and the sharing of injecting drug equipment in prisons has contributed to higher prevalence of bloodborne diseases in prisoners than in the general population. Few prison needle and syringe programs (PNSPs) exist. We conducted a systematic review to assess evidence regarding health outcomes of PNSPs. We searched peer-reviewed databases for data relating to needle and syringe programs in prisons. The search methodology was conducted in accordance with accepted guidelines. Five studies met review inclusion criteria, and all presented evidence associating PNSPs with one or more health benefits, but the strength of the evidence was low. The outcomes for which the studies collectively demonstrated the strongest evidence were prevention of human immunodeficiency virus and viral hepatitis. Few negative consequences from PNSPs were observed, consistent with previous evidence assessments. More research is needed on PNSP effectiveness, and innovative study designs are needed to overcome methodological limitations of previous research. Until stronger evidence becomes available, policymakers are urged to recognize that not implementing PNSPs has the potential to cause considerable harm, in light of what is currently known about the risks and benefits of needle and syringe programs and PNSPs and about the high prevalence of human immunodeficiency virus and viral hepatitis in prisons.

Entities:  

Mesh:

Year:  2018        PMID: 29659780     DOI: 10.1093/epirev/mxx019

Source DB:  PubMed          Journal:  Epidemiol Rev        ISSN: 0193-936X            Impact factor:   6.222


  7 in total

Review 1.  Safer tattooing interventions in prisons: a systematic review and call to action.

Authors:  Nguyen Toan Tran; Célestine Dubost; Stéphanie Baggio; Laurent Gétaz; Hans Wolff
Journal:  BMC Public Health       Date:  2018-08-15       Impact factor: 3.295

2.  Optimising opioid substitution therapy in the prison environment.

Authors:  Farrukh Alam; Nat Wright; Paul Roberts; Sunny Dhadley; Joanne Townley; Russell Webster
Journal:  Int J Prison Health       Date:  2019-12-05

3.  "My first 48 hours out": drug users' perspectives on challenges and strategies upon release from prison.

Authors:  Daniela Jamin; Wouter Vanderplasschen; Orphée Sys; Marie Jauffret-Roustide; Laurent Michel; Philippe Trouiller; Andreia Neisa; Mariana Homen; Vânia Mendes; Heino Stöver
Journal:  Harm Reduct J       Date:  2021-03-12

4.  The state of harm reduction in prisons in 30 European countries with a focus on people who inject drugs and infectious diseases.

Authors:  Heino Stöver; Anna Tarján; Gergely Horváth; Linda Montanari
Journal:  Harm Reduct J       Date:  2021-06-29

Review 5.  Identifying and managing infectious disease syndemics in patients with HIV.

Authors:  Daniel J Bromberg; Kenneth H Mayer; Frederick L Altice
Journal:  Curr Opin HIV AIDS       Date:  2020-07       Impact factor: 4.061

6.  Understanding and Improving the Health of People Who Experience Incarceration: An Overview and Synthesis.

Authors:  Stuart A Kinner; Jesse T Young
Journal:  Epidemiol Rev       Date:  2018-06-01       Impact factor: 6.222

7.  Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.

Authors:  Rob Bielen; Samya R Stumo; Rachel Halford; Klára Werling; Tatjana Reic; Heino Stöver; Geert Robaeys; Jeffrey V Lazarus
Journal:  Harm Reduct J       Date:  2018-05-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.